澳大利亚原住民与托雷斯海峡岛民腹膜透析的应用与结局:登记数据分析
该观察性研究分析2004至2020年登记数据,描述澳大利亚原住民与托雷斯海峡岛民以腹膜透析作为首次肾脏替代治疗的应用情况及结局。研究发现腹膜透析使用率从17.2%降至12.7%,腹膜炎粗发生率为0.53次/患者年,高于当前基准0.4次/患者年,且治愈率近期下降,需紧急关注。
要点
- 腹膜透析使用率从2004-2009年的17.2%降至2016-2020年的12.7%(P=0.002)
- 腹膜炎粗发生率为0.53次/患者年(95%CI 0.50-0.56),高于当前基准0.4次/患者年
- 腹膜炎治愈率从80.0%降至70.8%(P<0.001),需紧急关注
核心结论
- 原住民与托雷斯海峡岛民以腹膜透析作为首次肾脏替代治疗者,腹膜炎发生率高于当前基准0.4次/患者年,且近期治愈率恶化,需紧急解决肾脏照护差距。
研究设计与样本
- 观察性研究,分析2004年1月1日至2020年12月31日登记数据,纳入4604名原住民与托雷斯海峡岛民(占所有开始肾脏替代治疗澳大利亚人的10.4%)。
主要发现
- 665人(14.4%)以腹膜透析作为首次肾脏替代治疗方式。
- 腹膜透析使用率从2004-2009年的17.2%降至2016-2020年的12.7%(P=0.002)。
- 413人共发生1105次腹膜炎,中位每人3次(IQR 2-5);粗发生率为0.53次/患者年(95%CI 0.50-0.56),无显著时间变化;首次腹膜炎中位时间1.1年。
- 2016-2020年腹膜炎发生率比(IRR)为0.63(95%CI 0.52-0.77,P<0.001),低于2004-2009年参照;2010-2015年IRR为0.90(95%CI 0.76-1.07,P=0.23)。
- 治愈率从2004-2009年的80.0%(n=435)降至2016-2020年的70.8%(n=131)(P<0.001)。
临床怎么用
- 针对原住民与托雷斯海峡岛民腹膜透析患者,应关注腹膜炎高发风险及近期治愈率下降,加强腹膜炎防治与照护质量改进。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Peritoneal dialysis (PD) enables people to use kidney replacement therapy (KRT) outside of healthcare-dependent settings, a strong priority of Aboriginal and Torres Strait Islander people. METHODS: We undertook an observational study analyzing registry data to describe access to PD and its outcome as the first KRT among Aboriginal and Torres Strait Islander people between January 1, 2004 and December 31 2020. RESULTS: Out of 4604 Aboriginal and Torres Strait Islander people, reflecting 10.4% of all Australians commencing KRT, PD was the first KRT modality among 665 (14.4%). PD utilization was 17.2% in 2004 to 2009 and 12.7% in 2016 to 2020 (P = 0.002); 1105 episodes of peritonitis were observed in 413 individuals, median of 3 (interquartile range [IQR], 2-5) episodes/patient. The crude peritonitis rate was 0.53 (95% confidence interval [CI], 0.50-0.56) episodes/patient-years without any significant changes over time. The median time to first peritonitis was 1.1 years. A decrease in the peritonitis incidence rate ratio (IRR) was observed in 2016 to 2020 (IRR, 0.63 [95% CI, 0.52-0.77], P < 0.001) compared to earlier eras (2010-2015: IRR, 0.90 [95% CI, 0.76-1.07], P = 0.23; Ref: 2004-2009). The cure rates decreased from 80.0% (n = 435) in 2004 to 2009, to 70.8% (n = 131) in 2016 to 2020 (P < 0.001). CONCLUSION: Aboriginal and Torres Strait Islander people who utilized PD as their first KRT during 2004 to 2020 recorded a higher peritonitis rate than the current benchmark of 0.4 episodes/patient-years. The cure rates have worsened recently, which should be a big concern. There is an exigent need to address these gaps in kidney care for Aboriginal and Torres Strait Islander people.
引用
- Hayat A, Cho Y, Pascoe EM, et al. Uptake and Outcomes of Peritoneal Dialysis among Aboriginal and Torres Strait Islander People: Analysis of Registry Data. Kidney Int Rep. 2024. PMID: 38707791. doi:10.1016/j.ekir.2024.01.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。